ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,891.64
-0.25%
S&P 500
5,214.08
0.51%
Dow Jones
39,387.76
0.85%
US Dollar vs Yen
155.683
0.19%
Brent Oil
84.105
0.18%
Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC
  6. Alseres Pharmaceuticals Inc (CE) (ALSE)

  7. Alseres Pharmaceuticals Inc (CE) (ALSE) ニュース

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)
から:
次の項目別のソート:
 Showing the most relevant articles for your search:USOTC:ALSE
日付受信時刻ニュースソース見出しコード企業名
2014/11/2206 : 10Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/11/1905 : 09Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/08/1421 : 09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/05/2402 : 04Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/05/1622 : 46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/04/1021 : 52Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/04/0106 : 00Edgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2014/04/0106 : 00Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/07/3121 : 29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/05/1803 : 47Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/05/1703 : 44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/04/0202 : 23Edgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/02/2205 : 05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/02/0722 : 03Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/2904 : 40Edgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/2904 : 40Edgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/2904 : 37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/2902 : 40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/0900 : 21Edgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2013/01/0900 : 21Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/11/1420 : 08Edgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/11/1420 : 08Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/08/1319 : 16Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/07/2319 : 02Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/07/0221 : 30Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/06/1323 : 06Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/05/1204 : 18Edgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/05/0905 : 12Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/03/3005 : 50Edgar (US Regulatory)Annual Report (10-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
2012/03/2004 : 50Edgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ALSE

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
COIN
ETHUSD
Ethereum
COIN
BTCUSD
Bitcoin
COIN
SOLUSD
Solana
NYSE
MCD
McDonalds
NYSE
BAC
Bank of America
NYSE
VZ
Verizon Communications
CCOM
US100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
MRK
Merck
FX
USDGBP
US Dollar vs Sterling
USOTC
RHHBY
Roche (QX)
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
MSFT
Microsoft
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有